Expired
Lead Plaintiff Deadline
Feb 21, 2025
Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that AstraZeneca PLC made materially false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities; (3) as a result, AstraZeneca understated its legal risks; (4) the foregoing, once revealed, could materially harm AstraZeneca’s business activities in China; and (5) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
In order to be eligible to join the AZN class action lawsuit, you must have incurred a loss on shares of AstraZeneca purchased during the class period listed above.
If you suffered a loss in AstraZeneca during the relevant time frame or pursuant to the relevant offering(s), you have until February 21, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
